In line with this, it has been reported that melatonin administration can reduce depressive-like behaviour in an animal model of depression by reducing NLRP3 inflammasome activation through the activation of Nrf2 and the silent information regulator 2 homolog 1 (SIRT1), which have antioxidant actions [101]. Here, NFE2L2 is linked to major depressive disorder.